Neogen (NEOG) Cash from Investing Activities (2010 - 2026)
Neogen (NEOG) posted quarterly Cash from Investing Activities of -$4.0 million for Q2 2026, up 74.84% year-over-year from -$2.3 million in Q2 2025, and up 65.39% quarter-over-quarter from -$11.6 million in Q1 2026.
Neogen (NEOG) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Neogen's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$4.0 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 74.84% year-over-year to -$4.0 million; the TTM figure through May 2026 stood at $70.5 million (up 171.07% YoY), while the FY2026 annual figure was $70.5 million, up 171.07% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at -$4.0 million, up from -$11.6 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $97.7 million in Q3 2025, with the low at -$33.7 million in Q3 2024.
- The 5-year median for Cash from Investing Activities is -$11.6 million (2025), against an average of $6.1 million.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities jumped 421.32% in 2022, then tumbled 354.71% in 2024.
- Neogen's Cash from Investing Activities stood at $93.0 million in 2022, then plunged by 87.6% to $11.5 million in 2023, then slumped by 248.73% to -$17.2 million in 2024, then jumped by 31.99% to -$11.7 million in 2025, then soared by 65.72% to -$4.0 million in 2026.
- Business Quant data shows NEOG's Cash from Investing Activities at -$4.0 million in Q2 2026, -$11.6 million in Q1 2026, and -$11.7 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | -4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -4.00 Mn |
| May 31, 2026 | -4.00 Mn |
| Feb 28, 2026 | -11.56 Mn |
| Feb 28, 2026 | -11.56 Mn |
| Nov 30, 2025 | -11.67 Mn |
| Nov 30, 2025 | -11.67 Mn |
| Aug 31, 2025 | 97.73 Mn |
| Aug 31, 2025 | 97.73 Mn |
| May 31, 2025 | -15.90 Mn |
| May 31, 2025 | -15.90 Mn |
| Feb 28, 2025 | -32.48 Mn |
| Feb 28, 2025 | -32.48 Mn |
| Nov 30, 2024 | -17.16 Mn |
| Nov 30, 2024 | -17.16 Mn |
| Aug 31, 2024 | -33.66 Mn |
| Aug 31, 2024 | -33.66 Mn |
| May 31, 2024 | -17.52 Mn |
| May 31, 2024 | -17.52 Mn |
| Feb 29, 2024 | -14.64 Mn |
| Feb 29, 2024 | -14.64 Mn |